These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 27671863)

  • 21. Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors - a follow-up study of intraluminal-impedance guided therapy.
    Becker V; Bajbouj M; Waller K; Schmid RM; Meining A
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1355-60. PubMed ID: 17900268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oropharyngeal pH monitoring for laryngopharyngeal reflux: is it a reliable test before therapy?
    Vailati C; Mazzoleni G; Bondi S; Bussi M; Testoni PA; Passaretti S
    J Voice; 2013 Jan; 27(1):84-9. PubMed ID: 23159026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of super high dose proton pump inhibitor administration in refractory laryngopharyngeal reflux: a pilot study.
    Portnoy JE; Gregory ND; Cerulli CE; Hawkshaw MJ; Lurie D; Katz PO; Sataloff RT
    J Voice; 2014 May; 28(3):369-77. PubMed ID: 24495427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between extralaryngeal endoscopic findings, proton pump inhibitor (PPI) response, and pH measures in suspected laryngopharyngeal reflux.
    Agrawal N; Yadlapati R; Shabeeb N; Price CP; Lidder A; Shintani-Smith S; Bové M; Pandolfino J; Tan B
    Dis Esophagus; 2019 Apr; 32(4):. PubMed ID: 30101358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough.
    Ribolsi M; Savarino E; De Bortoli N; Balestrieri P; Furnari M; Martinucci I; Casale M; Greco F; Salvinelli F; Savarino V; Marchi S; Cicala M
    Aliment Pharmacol Ther; 2014 Oct; 40(8):966-73. PubMed ID: 25109844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patients with acid, high-fat and low-protein diet have higher laryngopharyngeal reflux episodes at the impedance-pH monitoring.
    Lechien JR; Bobin F; Muls V; Horoi M; Thill MP; Dequanter D; Rodriguez A; Saussez S
    Eur Arch Otorhinolaryngol; 2020 Feb; 277(2):511-520. PubMed ID: 31679054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multichannel intraluminal impedance in the evaluation of patients with persistent globus on proton pump inhibitor therapy.
    Anandasabapathy S; Jaffin BW
    Ann Otol Rhinol Laryngol; 2006 Aug; 115(8):563-70. PubMed ID: 16944654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laryngopharyngeal Reflux Disease is More Severe in Obese Patients: A Prospective Multicenter Study.
    Lechien JR; Bobin F; Muls V; Saussez S; Hans S
    Laryngoscope; 2021 Nov; 131(11):E2742-E2748. PubMed ID: 34086292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of Gastro-esophageal Reflux Disease in Suspected Laryngo- pharingeal Reflux Unresponsive to Proton-pump Inhibitors.
    Tursi A; Palieri AP; Tiano M; Elisei W
    Rev Recent Clin Trials; 2021; 16(4):390-395. PubMed ID: 34365960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The importance of combined 24-hour multichannel intraluminal impedance-pH monitoring in the evaluation of children with suspected laryngopharyngeal reflux.
    Pavić I; Babić I; Čepin Bogović J; Hojsak I
    Clin Otolaryngol; 2017 Jun; 42(3):544-549. PubMed ID: 27727523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring.
    Mainie I; Tutuian R; Shay S; Vela M; Zhang X; Sifrim D; Castell DO
    Gut; 2006 Oct; 55(10):1398-402. PubMed ID: 16556669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between oropharyngeal pH-monitoring and esophageal pH-impedance monitoring in patients with suspected GERD-related extra-esophageal symptoms.
    Mazzoleni G; Vailati C; Lisma DG; Testoni PA; Passaretti S
    Neurogastroenterol Motil; 2014 Nov; 26(11):1557-64. PubMed ID: 25208949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Twice-daily proton pump inhibitor therapy does not decrease the frequency of reflux episodes during nocturnal recumbency in patients with refractory GERD: analysis of 200 patients using multichannel intraluminal impedance-pH testing.
    Clayton SB; Rife CC; Singh ER; Kalbfleisch JH; Castell DO
    Dis Esophagus; 2012; 25(8):682-6. PubMed ID: 22292567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do laryngoscopic findings reflect the characteristics of reflux in patients with laryngopharyngeal reflux?
    Lee YC; Kwon OE; Park JM; Eun YG
    Clin Otolaryngol; 2018 Feb; 43(1):137-143. PubMed ID: 28605121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of age on treatment with proton pump inhibitors in patients with laryngopharyngeal reflux disease: a prospective multicenter study.
    Lee YC; Lee JS; Kim SW; Kwon KH; Eun YG
    JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1291-5. PubMed ID: 24201320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of baseline impedance in patients with proton pump inhibitor-refractory nonerosive reflux disease.
    Kohata Y; Fujiwara Y; Yamagami H; Tanigawa T; Shiba M; Watanabe K; Watanabe T; Tominaga K; Arakawa T
    J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():36-40. PubMed ID: 25827802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of the efficacy of proton-pump inhibitors in patients with contact granuloma using 24-hour combined dual channel pH/impedance monitoring.
    Kim BH; Park H; Shin CM; Huh G; Jung YH; Jeong WJ
    Auris Nasus Larynx; 2024 Jun; 51(3):548-552. PubMed ID: 38537558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Esophageal motor dysfunction plays a key role in GERD with globus sensation--analysis of factors promoting resistance to PPI therapy.
    Tsutsui H; Manabe N; Uno M; Imamura H; Kamada T; Kusunoki H; Shiotani A; Hata J; Harada T; Haruma K
    Scand J Gastroenterol; 2012 Sep; 47(8-9):893-9. PubMed ID: 22594305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined esophageal multichannel intraluminal impedance and pH monitoring (MII -pH) in the diagnostics and treatment of gastroesophageal reflux disease and its complications.
    Masiak W; Wallner G; Wallner J; Pedowski T; Solecki M
    Pol Przegl Chir; 2011 Sep; 83(9):488-96. PubMed ID: 22166737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.